Publications by authors named "Tracey Haigh"

Claim this Profile
D
Defects in NK cell immunity of pediatric cancer patients revealed by deep immune profiling.
Eleni Syrimi, Naeem Khan, Paul Murray, Carrie Willcox, Tracey Haigh

iScience· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heightened Epstein-Barr virus immunity and potential cross-reactivities in multiple sclerosis.
Olivia G Thomas, Tracey A Haigh, Deborah Croom-Carter, Alison Leese, Yolanda Van Wijck

PLoS Pathog· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioengineered small extracellular vesicles deliver multiple SARS-CoV-2 antigenic fragments and drive a broad immunological response.
Hannah K Jackson, Heather M Long, Juan Carlos Yam-Puc, Roberta Palmulli, Tracey A Haigh

J Extracell Vesicles· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural definition of HLA class II-presented SARS-CoV-2 epitopes reveals a mechanism to escape pre-existing CD4 T cell immunity.
Yuan Chen, Georgina H Mason, D Oliver Scourfield, Alexander Greenshields-Watson, Tracey A Haigh

Cell Rep· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutations in SARS-CoV-2 spike protein impair epitope-specific CD4 T cell recognition.
Emily X C Tye, Elizabeth Jinks, Tracey A Haigh, Baksho Kaul, Prashant Patel

Nat Immunol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytotoxic CD4+ T-cells specific for EBV capsid antigen BORF1 are maintained in long-term latently infected healthy donors.
Alexander C Dowell, Tracey A Haigh, Gordon B Ryan, James E Turner, Heather M Long

PLoS Pathog· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterologous prime-boost vaccination protects against EBV antigen-expressing lymphomas.
Julia Rühl, Carmen Citterio, Christine Engelmann, Tracey Haigh, Andrzej Dzionek

J Clin Invest· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Robust T-cell stimulation by Epstein-Barr virus-transformed B cells after antigen targeting to DEC-205.
Carol S Leung, Michael A Maurer, Sonja Meixlsperger, Anne Lippmann, Cheolho Cheong, Tracey A Haigh

Blood· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epstein-Barr virus evades CD4+ T cell responses in lytic cycle through BZLF1-mediated downregulation of CD74 and the cooperation of vBcl-2.
Jianmin Zuo, Wendy A Thomas, Tracey A Haigh, Leah Fitzsimmons, Heather M Long

PLoS Pathog· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of tetraspanin CD63 in antigen presentation via MHC class II.
Sven H Petersen, Elena Odintsova, Tracey A Haigh, Alan B Rickinson, Graham S Taylor

Eur J Immunol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel latent membrane 2 transcript expressed in Epstein-Barr virus-positive NK- and T-cell lymphoproliferative disease encodes a target for cellular immunotherapy.
Christopher P Fox, Tracey A Haigh, Graham S Taylor, Heather M Long, Steven P Lee

Blood· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nuclear location of an endogenously expressed antigen, EBNA1, restricts access to macroautophagy and the range of CD4 epitope display.
Carol S Leung, Tracey A Haigh, Laura K Mackay, Alan B Rickinson, Graham S Taylor

Proc Natl Acad Sci U S A· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EBV latent membrane proteins (LMPs) 1 and 2 as immunotherapeutic targets: LMP-specific CD4+ cytotoxic T cell recognition of EBV-transformed B cell lines.
Tracey A Haigh, Xiaorong Lin, Hui Jia, Edwin P Hui, Anthony T C Chan

J Immunol· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A role for intercellular antigen transfer in the recognition of EBV-transformed B cell lines by EBV nuclear antigen-specific CD4+ T cells.
Graham S Taylor, Heather M Long, Tracey A Haigh, Martin Larsen, Jill Brooks

J Immunol· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EBV-specific CD4+ T cell clones exhibit vigorous allogeneic responses.
Elise Landais, Alexis Morice, Heather M Long, Tracey A Haigh, Béatrice Charreau

J Immunol· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regression of Epstein-Barr virus-induced B-cell transformation in vitro involves virus-specific CD8+ T cells as the principal effectors and a novel CD4+ T-cell reactivity.
Nancy H Gudgeon, Graham S Taylor, Heather M Long, Tracey A Haigh, Alan B Rickinson

J Virol· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD8 T cell recognition of endogenously expressed epstein-barr virus nuclear antigen 1.
Steven P Lee, Jill M Brooks, Hatim Al-Jarrah, Wendy A Thomas, Tracey A Haigh

J Exp Med· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a TAP-independent, immunoproteasome-dependent CD8+ T-cell epitope in Epstein-Barr virus latent membrane protein 2.
Georg Lautscham, Tracey Haigh, Sabine Mayrhofer, Graham Taylor, Debbie Croom-Carter

J Virol· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adenovirally transduced dendritic cells induce bispecific cytotoxic T lymphocyte responses against adenovirus and cytomegalovirus pp65 or against adenovirus and Epstein-Barr virus EBNA3C protein: a novel approach for immunotherapy.
Yamina Hamel, Neil Blake, Susanne Gabrielsson, Tracey Haigh, Karin Jooss

Hum Gene Ther· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis